Theorem Clinical Research

Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


Parexel expands Perceptive Partner Program, adds CRF Health and Clinical Ink

Monday, September 15, 2014 12:41 PM

Parexel International, a Massachusetts-based global biopharmaceutical services organization, has announced that clinical technology companies CRF Health, a provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials, and Clinical Ink, a Winston-Salem, N.C.-based eSource solutions company, have joined its Perceptive Partner Program. 

More... »


Lupus Research Institute holds NYC's first Lupus Trials Fair

Monday, September 15, 2014 12:39 PM

Over 200 patients, families, physicians and scientists came together under one roof last Friday, Sept. 12, to learn, interact and participate in the drive for better lupus treatments at New York City's first Lupus Trials Fair, launched by the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation.

More... »


Trialbee helps AstraZeneca reduce recruitment time of patients to clinical trials

Monday, September 15, 2014 12:38 PM

Swedish e-health company Trialbee has signed a professional service agreement with AstraZeneca for e-recruitment.

More... »

PRA Health Sciences files for initial public offering

Monday, September 15, 2014 12:37 PM

PRA Health Sciences, a Raleigh, N.C.-based CRO, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) of shares of its common stock by PRA Health Sciences and an affiliate of Kohlberg Kravis Roberts (the selling stockholder). The number of shares to be offered and the price range has not yet been determined.

More... »

Novartis to open Center for Advanced Cellular Therapeutics at University of Pennsylvania

Monday, September 15, 2014 12:29 PM

The University of Pennsylvania’s alliance with Novartis has unveiled plans for the construction of a first-of-its-kind Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia.

More... »

Quintiles launches new customer solution

Monday, September 15, 2014 12:21 PM

Global CRO Quintiles has launched the Quintiles Emerging Biopharma Solution, a new offering designed to meet the unique clinical development needs and goals of emerging biopharmaceutical companies in the global marketplace.

More... »

Health advocate coalition says EMA advice for fee undermines independence of regulatory authorities

Monday, September 15, 2014 12:18 PM

Health Action International Europe (HAI Europe), the International Society of Drug Bulletins (ISDB), the Medicines in Europe Forum (MiEF) and the Association Internationale de la Mutualité (AIM) have criticized the EMA for providing confidential “advice” to pharmaceutical companies on their development plans for new medicines in exchange for fees—a potentially harmful practice the EMA now is trying to extend to national health technology assessment (HTA) bodies in the E.U.

More... »

Evaluating study coordinators

Monday, September 15, 2014 07:00 AM

It is important to realize what is really important in both site and staff selection.

More... »

Lilly’s CYRAMZA phase III colorectal cancer trial meets primary endpoint

Friday, September 12, 2014 01:35 PM

Eli Lilly has announced that the RAISE trial, a phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival. The global, randomized, double-blind study compared ramucirumab plus FOLFIRI to placebo plus FOLFIRI as a second-line treatment in patients with mCRC after treatment with bevacizumab, oxaliplatin and a fluoropyrimidine in the first-line setting.

More... »

Cellerant awarded $47.5M for development of CLT-008 for acute radiation syndrome

Friday, September 12, 2014 01:16 PM

Cellerant Therapeutics, a California biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, has been awarded $47.5 million under a second option exercised by the Biomedical Advanced Research and Development Authority (BARDA) in the office of the assistant secretary for preparedness and response of the department of Health and Human Services.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 29

WCG sees ePharmaSolutions’ clinical trial portal as the next step in the data evolution, company mission

Cutting-edge advertising can ‘break through the clutter’ for successful patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs